Home » Topics » BioWorld Science

BioWorld Science
RSS

Beijing Jacobio Pharmaceuticals presents new AURK1 inhibitors

Aug. 16, 2021

Kangpu Biopharmaceuticals divulges CRBN-binding isoindolines

Aug. 16, 2021

MedImmune patents new ADCs for cancer

Aug. 16, 2021

TYK2 inhibitor NDI-034858 enters phase II investigation for plaque psoriasis

Aug. 16, 2021

Trial starts enrollment to assess LY-3361237 in patients with psoriasis

Aug. 16, 2021

Phase I trial begins for DVX-201 allogeneic NK cells in COVID-19 patients

Aug. 16, 2021

Polymer-mediated "immunocloaking" - A new paradigm for combating transplant rejection?

Aug. 16, 2021

SARS-CoV-2 spike ectodomain protein StriFK vaccine with adjuvant reduces transmission in animals

Aug. 13, 2021

Phase I/II study of ChulaCov19 vaccine initiates at Chulalongkorn University

Aug. 13, 2021

Moderna initiates phase I/II study of mRNA-3705 in methylmalonic acidemia

Aug. 13, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 3, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...